Global Parkinson's Disease Therapeutics Market Research Report 2026(Status and Outlook)
Parkinson?s Disease therapeutics refer to a class of drugs designed to alleviate or slow the progression of both motor and non-motor symptoms in patients with Parkinson?s Disease. These include dopamine replacement therapies, dopamine receptor agonists, monoamine oxidase-B inhibitors, catechol-O-methyltransferase inhibitors, and emerging neuroprotective or gene-based treatments. The main therapeutic goal is to restore dopaminergic balance in the brain, improving symptoms such as tremor, rigidity, and bradykinesia. The industry focus is shifting from symptomatic relief toward disease-modifying mechanisms, with notable progress in ?-synuclein aggregation inhibition, neural regeneration, and precision drug delivery. Advances in biotechnology and neuroimaging have encouraged interdisciplinary collaborations, expanding drug types beyond small molecules to RNA therapies, cell-based approaches, and gene editing. Despite challenges such as diminishing efficacy over time, individual variability, and central nervous system delivery barriers, innovation and investment activity remain strong. The sector is expected to evolve toward personalized, long-acting, and disease-modifying therapeutic strategies.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Parkinson's Disease Therapeutics market size was estimated at USD 2783.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Parkinson's Disease Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Parkinson's Disease Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Parkinson's Disease Therapeutics market.
Global Parkinson's Disease Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Roche
H.Lundbeck
Bausch Health
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Desitin Arzneimittel
Endo Pharmaceuticals
Market Segmentation (by Type)
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
Market Segmentation (by Application)
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Parkinson's Disease Therapeutics Market
Overview of the regional outlook of the Parkinson's Disease Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson's Disease Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Parkinson's Disease Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Parkinson's Disease Therapeutics market size was estimated at USD 2783.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Parkinson's Disease Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Parkinson's Disease Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Parkinson's Disease Therapeutics market.
Global Parkinson's Disease Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Roche
H.Lundbeck
Bausch Health
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Desitin Arzneimittel
Endo Pharmaceuticals
Market Segmentation (by Type)
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
Market Segmentation (by Application)
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Parkinson's Disease Therapeutics Market
Overview of the regional outlook of the Parkinson's Disease Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson's Disease Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Parkinson's Disease Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Parkinson's Disease Therapeutics
1.2 Key Market Segments
1.2.1 Parkinson's Disease Therapeutics Segment by Type
1.2.2 Parkinson's Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSON'S DISEASE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson's Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Parkinson's Disease Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSON'S DISEASE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Parkinson's Disease Therapeutics Product Life Cycle
3.3 Global Parkinson's Disease Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Parkinson's Disease Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Parkinson's Disease Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Parkinson's Disease Therapeutics Market Competitive Situation and Trends
3.8.1 Parkinson's Disease Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Parkinson's Disease Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PARKINSON'S DISEASE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson's Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON'S DISEASE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Parkinson's Disease Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Parkinson's Disease Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 PARKINSON'S DISEASE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson's Disease Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Parkinson's Disease Therapeutics Market Size by Type (2020-2025)
6.4 Global Parkinson's Disease Therapeutics Price by Type (2020-2025)
7 PARKINSON'S DISEASE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson's Disease Therapeutics Market Sales by Application (2020-2025)
7.3 Global Parkinson's Disease Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2020-2025)
8 PARKINSON'S DISEASE THERAPEUTICS MARKET SALES BY REGION
8.1 Global Parkinson's Disease Therapeutics Sales by Region
8.1.1 Global Parkinson's Disease Therapeutics Sales by Region
8.1.2 Global Parkinson's Disease Therapeutics Sales Market Share by Region
8.2 Global Parkinson's Disease Therapeutics Market Size by Region
8.2.1 Global Parkinson's Disease Therapeutics Market Size by Region
8.2.2 Global Parkinson's Disease Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Parkinson's Disease Therapeutics Sales by Country
8.3.2 North America Parkinson's Disease Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Parkinson's Disease Therapeutics Sales by Country
8.4.2 Europe Parkinson's Disease Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Parkinson's Disease Therapeutics Sales by Region
8.5.2 Asia Pacific Parkinson's Disease Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Parkinson's Disease Therapeutics Sales by Country
8.6.2 South America Parkinson's Disease Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Parkinson's Disease Therapeutics Sales by Region
8.7.2 Middle East and Africa Parkinson's Disease Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PARKINSON'S DISEASE THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Parkinson's Disease Therapeutics by Region(2020-2025)
9.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Parkinson's Disease Therapeutics Production
9.4.1 North America Parkinson's Disease Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Parkinson's Disease Therapeutics Production
9.5.1 Europe Parkinson's Disease Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Parkinson's Disease Therapeutics Production (2020-2025)
9.6.1 Japan Parkinson's Disease Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Parkinson's Disease Therapeutics Production (2020-2025)
9.7.1 China Parkinson's Disease Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Parkinson's Disease Therapeutics Product Overview
10.1.3 Merck Parkinson's Disease Therapeutics Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Akorn
10.2.1 Akorn Basic Information
10.2.2 Akorn Parkinson's Disease Therapeutics Product Overview
10.2.3 Akorn Parkinson's Disease Therapeutics Product Market Performance
10.2.4 Akorn Business Overview
10.2.5 Akorn SWOT Analysis
10.2.6 Akorn Recent Developments
10.3 GSK
10.3.1 GSK Basic Information
10.3.2 GSK Parkinson's Disease Therapeutics Product Overview
10.3.3 GSK Parkinson's Disease Therapeutics Product Market Performance
10.3.4 GSK Business Overview
10.3.5 GSK SWOT Analysis
10.3.6 GSK Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Parkinson's Disease Therapeutics Product Overview
10.4.3 Novartis Parkinson's Disease Therapeutics Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Basic Information
10.5.2 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Overview
10.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Market Performance
10.5.4 Boehringer Ingelheim Business Overview
10.5.5 Boehringer Ingelheim Recent Developments
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Basic Information
10.6.2 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Overview
10.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Market Performance
10.6.4 Teva Pharmaceutical Business Overview
10.6.5 Teva Pharmaceutical Recent Developments
10.7 Abbvie
10.7.1 Abbvie Basic Information
10.7.2 Abbvie Parkinson's Disease Therapeutics Product Overview
10.7.3 Abbvie Parkinson's Disease Therapeutics Product Market Performance
10.7.4 Abbvie Business Overview
10.7.5 Abbvie Recent Developments
10.8 Kyowa Hakko Kirin Pharma
10.8.1 Kyowa Hakko Kirin Pharma Basic Information
10.8.2 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Overview
10.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Market Performance
10.8.4 Kyowa Hakko Kirin Pharma Business Overview
10.8.5 Kyowa Hakko Kirin Pharma Recent Developments
10.9 Astellas Pharma
10.9.1 Astellas Pharma Basic Information
10.9.2 Astellas Pharma Parkinson's Disease Therapeutics Product Overview
10.9.3 Astellas Pharma Parkinson's Disease Therapeutics Product Market Performance
10.9.4 Astellas Pharma Business Overview
10.9.5 Astellas Pharma Recent Developments
10.10 Roche
10.10.1 Roche Basic Information
10.10.2 Roche Parkinson's Disease Therapeutics Product Overview
10.10.3 Roche Parkinson's Disease Therapeutics Product Market Performance
10.10.4 Roche Business Overview
10.10.5 Roche Recent Developments
10.11 H.Lundbeck
10.11.1 H.Lundbeck Basic Information
10.11.2 H.Lundbeck Parkinson's Disease Therapeutics Product Overview
10.11.3 H.Lundbeck Parkinson's Disease Therapeutics Product Market Performance
10.11.4 H.Lundbeck Business Overview
10.11.5 H.Lundbeck Recent Developments
10.12 Bausch Health
10.12.1 Bausch Health Basic Information
10.12.2 Bausch Health Parkinson's Disease Therapeutics Product Overview
10.12.3 Bausch Health Parkinson's Disease Therapeutics Product Market Performance
10.12.4 Bausch Health Business Overview
10.12.5 Bausch Health Recent Developments
10.13 Apokyn
10.13.1 Apokyn Basic Information
10.13.2 Apokyn Parkinson's Disease Therapeutics Product Overview
10.13.3 Apokyn Parkinson's Disease Therapeutics Product Market Performance
10.13.4 Apokyn Business Overview
10.13.5 Apokyn Recent Developments
10.14 Orion
10.14.1 Orion Basic Information
10.14.2 Orion Parkinson's Disease Therapeutics Product Overview
10.14.3 Orion Parkinson's Disease Therapeutics Product Market Performance
10.14.4 Orion Business Overview
10.14.5 Orion Recent Developments
10.15 Stada Arzneimittel
10.15.1 Stada Arzneimittel Basic Information
10.15.2 Stada Arzneimittel Parkinson's Disease Therapeutics Product Overview
10.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Product Market Performance
10.15.4 Stada Arzneimittel Business Overview
10.15.5 Stada Arzneimittel Recent Developments
10.16 US WorldMeds
10.16.1 US WorldMeds Basic Information
10.16.2 US WorldMeds Parkinson's Disease Therapeutics Product Overview
10.16.3 US WorldMeds Parkinson's Disease Therapeutics Product Market Performance
10.16.4 US WorldMeds Business Overview
10.16.5 US WorldMeds Recent Developments
10.17 Desitin Arzneimittel
10.17.1 Desitin Arzneimittel Basic Information
10.17.2 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Overview
10.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Market Performance
10.17.4 Desitin Arzneimittel Business Overview
10.17.5 Desitin Arzneimittel Recent Developments
10.18 Endo Pharmaceuticals
10.18.1 Endo Pharmaceuticals Basic Information
10.18.2 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Overview
10.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Market Performance
10.18.4 Endo Pharmaceuticals Business Overview
10.18.5 Endo Pharmaceuticals Recent Developments
11 PARKINSON'S DISEASE THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Parkinson's Disease Therapeutics Market Size Forecast
11.2 Global Parkinson's Disease Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Parkinson's Disease Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Parkinson's Disease Therapeutics Market Size Forecast by Region
11.2.4 South America Parkinson's Disease Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Parkinson's Disease Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Parkinson's Disease Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Parkinson's Disease Therapeutics by Type (2026-2035)
12.1.2 Global Parkinson's Disease Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Parkinson's Disease Therapeutics by Type (2026-2035)
12.2 Global Parkinson's Disease Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Parkinson's Disease Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Parkinson's Disease Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Parkinson's Disease Therapeutics
1.2 Key Market Segments
1.2.1 Parkinson's Disease Therapeutics Segment by Type
1.2.2 Parkinson's Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSON'S DISEASE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson's Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Parkinson's Disease Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSON'S DISEASE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Parkinson's Disease Therapeutics Product Life Cycle
3.3 Global Parkinson's Disease Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Parkinson's Disease Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Parkinson's Disease Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Parkinson's Disease Therapeutics Market Competitive Situation and Trends
3.8.1 Parkinson's Disease Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Parkinson's Disease Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PARKINSON'S DISEASE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson's Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON'S DISEASE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Parkinson's Disease Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Parkinson's Disease Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 PARKINSON'S DISEASE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson's Disease Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Parkinson's Disease Therapeutics Market Size by Type (2020-2025)
6.4 Global Parkinson's Disease Therapeutics Price by Type (2020-2025)
7 PARKINSON'S DISEASE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson's Disease Therapeutics Market Sales by Application (2020-2025)
7.3 Global Parkinson's Disease Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2020-2025)
8 PARKINSON'S DISEASE THERAPEUTICS MARKET SALES BY REGION
8.1 Global Parkinson's Disease Therapeutics Sales by Region
8.1.1 Global Parkinson's Disease Therapeutics Sales by Region
8.1.2 Global Parkinson's Disease Therapeutics Sales Market Share by Region
8.2 Global Parkinson's Disease Therapeutics Market Size by Region
8.2.1 Global Parkinson's Disease Therapeutics Market Size by Region
8.2.2 Global Parkinson's Disease Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Parkinson's Disease Therapeutics Sales by Country
8.3.2 North America Parkinson's Disease Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Parkinson's Disease Therapeutics Sales by Country
8.4.2 Europe Parkinson's Disease Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Parkinson's Disease Therapeutics Sales by Region
8.5.2 Asia Pacific Parkinson's Disease Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Parkinson's Disease Therapeutics Sales by Country
8.6.2 South America Parkinson's Disease Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Parkinson's Disease Therapeutics Sales by Region
8.7.2 Middle East and Africa Parkinson's Disease Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PARKINSON'S DISEASE THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Parkinson's Disease Therapeutics by Region(2020-2025)
9.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Parkinson's Disease Therapeutics Production
9.4.1 North America Parkinson's Disease Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Parkinson's Disease Therapeutics Production
9.5.1 Europe Parkinson's Disease Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Parkinson's Disease Therapeutics Production (2020-2025)
9.6.1 Japan Parkinson's Disease Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Parkinson's Disease Therapeutics Production (2020-2025)
9.7.1 China Parkinson's Disease Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Parkinson's Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Parkinson's Disease Therapeutics Product Overview
10.1.3 Merck Parkinson's Disease Therapeutics Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Akorn
10.2.1 Akorn Basic Information
10.2.2 Akorn Parkinson's Disease Therapeutics Product Overview
10.2.3 Akorn Parkinson's Disease Therapeutics Product Market Performance
10.2.4 Akorn Business Overview
10.2.5 Akorn SWOT Analysis
10.2.6 Akorn Recent Developments
10.3 GSK
10.3.1 GSK Basic Information
10.3.2 GSK Parkinson's Disease Therapeutics Product Overview
10.3.3 GSK Parkinson's Disease Therapeutics Product Market Performance
10.3.4 GSK Business Overview
10.3.5 GSK SWOT Analysis
10.3.6 GSK Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Parkinson's Disease Therapeutics Product Overview
10.4.3 Novartis Parkinson's Disease Therapeutics Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Basic Information
10.5.2 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Overview
10.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Market Performance
10.5.4 Boehringer Ingelheim Business Overview
10.5.5 Boehringer Ingelheim Recent Developments
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Basic Information
10.6.2 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Overview
10.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Market Performance
10.6.4 Teva Pharmaceutical Business Overview
10.6.5 Teva Pharmaceutical Recent Developments
10.7 Abbvie
10.7.1 Abbvie Basic Information
10.7.2 Abbvie Parkinson's Disease Therapeutics Product Overview
10.7.3 Abbvie Parkinson's Disease Therapeutics Product Market Performance
10.7.4 Abbvie Business Overview
10.7.5 Abbvie Recent Developments
10.8 Kyowa Hakko Kirin Pharma
10.8.1 Kyowa Hakko Kirin Pharma Basic Information
10.8.2 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Overview
10.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Market Performance
10.8.4 Kyowa Hakko Kirin Pharma Business Overview
10.8.5 Kyowa Hakko Kirin Pharma Recent Developments
10.9 Astellas Pharma
10.9.1 Astellas Pharma Basic Information
10.9.2 Astellas Pharma Parkinson's Disease Therapeutics Product Overview
10.9.3 Astellas Pharma Parkinson's Disease Therapeutics Product Market Performance
10.9.4 Astellas Pharma Business Overview
10.9.5 Astellas Pharma Recent Developments
10.10 Roche
10.10.1 Roche Basic Information
10.10.2 Roche Parkinson's Disease Therapeutics Product Overview
10.10.3 Roche Parkinson's Disease Therapeutics Product Market Performance
10.10.4 Roche Business Overview
10.10.5 Roche Recent Developments
10.11 H.Lundbeck
10.11.1 H.Lundbeck Basic Information
10.11.2 H.Lundbeck Parkinson's Disease Therapeutics Product Overview
10.11.3 H.Lundbeck Parkinson's Disease Therapeutics Product Market Performance
10.11.4 H.Lundbeck Business Overview
10.11.5 H.Lundbeck Recent Developments
10.12 Bausch Health
10.12.1 Bausch Health Basic Information
10.12.2 Bausch Health Parkinson's Disease Therapeutics Product Overview
10.12.3 Bausch Health Parkinson's Disease Therapeutics Product Market Performance
10.12.4 Bausch Health Business Overview
10.12.5 Bausch Health Recent Developments
10.13 Apokyn
10.13.1 Apokyn Basic Information
10.13.2 Apokyn Parkinson's Disease Therapeutics Product Overview
10.13.3 Apokyn Parkinson's Disease Therapeutics Product Market Performance
10.13.4 Apokyn Business Overview
10.13.5 Apokyn Recent Developments
10.14 Orion
10.14.1 Orion Basic Information
10.14.2 Orion Parkinson's Disease Therapeutics Product Overview
10.14.3 Orion Parkinson's Disease Therapeutics Product Market Performance
10.14.4 Orion Business Overview
10.14.5 Orion Recent Developments
10.15 Stada Arzneimittel
10.15.1 Stada Arzneimittel Basic Information
10.15.2 Stada Arzneimittel Parkinson's Disease Therapeutics Product Overview
10.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Product Market Performance
10.15.4 Stada Arzneimittel Business Overview
10.15.5 Stada Arzneimittel Recent Developments
10.16 US WorldMeds
10.16.1 US WorldMeds Basic Information
10.16.2 US WorldMeds Parkinson's Disease Therapeutics Product Overview
10.16.3 US WorldMeds Parkinson's Disease Therapeutics Product Market Performance
10.16.4 US WorldMeds Business Overview
10.16.5 US WorldMeds Recent Developments
10.17 Desitin Arzneimittel
10.17.1 Desitin Arzneimittel Basic Information
10.17.2 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Overview
10.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Market Performance
10.17.4 Desitin Arzneimittel Business Overview
10.17.5 Desitin Arzneimittel Recent Developments
10.18 Endo Pharmaceuticals
10.18.1 Endo Pharmaceuticals Basic Information
10.18.2 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Overview
10.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Market Performance
10.18.4 Endo Pharmaceuticals Business Overview
10.18.5 Endo Pharmaceuticals Recent Developments
11 PARKINSON'S DISEASE THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Parkinson's Disease Therapeutics Market Size Forecast
11.2 Global Parkinson's Disease Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Parkinson's Disease Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Parkinson's Disease Therapeutics Market Size Forecast by Region
11.2.4 South America Parkinson's Disease Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Parkinson's Disease Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Parkinson's Disease Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Parkinson's Disease Therapeutics by Type (2026-2035)
12.1.2 Global Parkinson's Disease Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Parkinson's Disease Therapeutics by Type (2026-2035)
12.2 Global Parkinson's Disease Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Parkinson's Disease Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Parkinson's Disease Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Parkinson's Disease Therapeutics Market Size by Type (M USD)
Table 4. Global Parkinson's Disease Therapeutics Market Size by Application
Table 5. Parkinson's Disease Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Parkinson's Disease Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Parkinson's Disease Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Parkinson's Disease Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Parkinson's Disease Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2025)
Table 11. Global Market Parkinson's Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Parkinson's Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson's Disease Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Parkinson's Disease Therapeutics Sales by Type (K Units)
Table 27. Global Parkinson's Disease Therapeutics Market Size by Type (M USD)
Table 28. Global Parkinson's Disease Therapeutics Sales (K Units) by Type (2020-2025)
Table 29. Global Parkinson's Disease Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Parkinson's Disease Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Parkinson's Disease Therapeutics Market Share by Type (2020-2025)
Table 32. Global Parkinson's Disease Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Parkinson's Disease Therapeutics Sales (K Units) by Application
Table 34. Global Parkinson's Disease Therapeutics Market Size by Application
Table 35. Global Parkinson's Disease Therapeutics Sales by Application (2020-2025) & (K Units)
Table 36. Global Parkinson's Disease Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Parkinson's Disease Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Parkinson's Disease Therapeutics Market Share by Application (2020-2025)
Table 39. Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Parkinson's Disease Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. Global Parkinson's Disease Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Parkinson's Disease Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Parkinson's Disease Therapeutics Market Size by Region (2020-2025)
Table 44. North America Parkinson's Disease Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. North America Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Parkinson's Disease Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Parkinson's Disease Therapeutics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Parkinson's Disease Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Parkinson's Disease Therapeutics Sales by Country (2020-2025) & (K Units)
Table 51. South America Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Parkinson's Disease Therapeutics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Parkinson's Disease Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Parkinson's Disease Therapeutics Production (K Units) by Region(2020-2025)
Table 55. Global Parkinson's Disease Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Parkinson's Disease Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck Parkinson's Disease Therapeutics Product Overview
Table 64. Merck Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Akorn Basic Information
Table 69. Akorn Parkinson's Disease Therapeutics Product Overview
Table 70. Akorn Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Akorn Business Overview
Table 72. Akorn SWOT Analysis
Table 73. Akorn Recent Developments
Table 74. GSK Basic Information
Table 75. GSK Parkinson's Disease Therapeutics Product Overview
Table 76. GSK Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. GSK Business Overview
Table 78. GSK SWOT Analysis
Table 79. GSK Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Parkinson's Disease Therapeutics Product Overview
Table 82. Novartis Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Boehringer Ingelheim Basic Information
Table 86. Boehringer Ingelheim Parkinson's Disease Therapeutics Product Overview
Table 87. Boehringer Ingelheim Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Recent Developments
Table 90. Teva Pharmaceutical Basic Information
Table 91. Teva Pharmaceutical Parkinson's Disease Therapeutics Product Overview
Table 92. Teva Pharmaceutical Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Teva Pharmaceutical Business Overview
Table 94. Teva Pharmaceutical Recent Developments
Table 95. Abbvie Basic Information
Table 96. Abbvie Parkinson's Disease Therapeutics Product Overview
Table 97. Abbvie Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Abbvie Business Overview
Table 99. Abbvie Recent Developments
Table 100. Kyowa Hakko Kirin Pharma Basic Information
Table 101. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Overview
Table 102. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Kyowa Hakko Kirin Pharma Business Overview
Table 104. Kyowa Hakko Kirin Pharma Recent Developments
Table 105. Astellas Pharma Basic Information
Table 106. Astellas Pharma Parkinson's Disease Therapeutics Product Overview
Table 107. Astellas Pharma Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Astellas Pharma Business Overview
Table 109. Astellas Pharma Recent Developments
Table 110. Roche Basic Information
Table 111. Roche Parkinson's Disease Therapeutics Product Overview
Table 112. Roche Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Roche Business Overview
Table 114. Roche Recent Developments
Table 115. H.Lundbeck Basic Information
Table 116. H.Lundbeck Parkinson's Disease Therapeutics Product Overview
Table 117. H.Lundbeck Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. H.Lundbeck Business Overview
Table 119. H.Lundbeck Recent Developments
Table 120. Bausch Health Basic Information
Table 121. Bausch Health Parkinson's Disease Therapeutics Product Overview
Table 122. Bausch Health Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Bausch Health Business Overview
Table 124. Bausch Health Recent Developments
Table 125. Apokyn Basic Information
Table 126. Apokyn Parkinson's Disease Therapeutics Product Overview
Table 127. Apokyn Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Apokyn Business Overview
Table 129. Apokyn Recent Developments
Table 130. Orion Basic Information
Table 131. Orion Parkinson's Disease Therapeutics Product Overview
Table 132. Orion Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Orion Business Overview
Table 134. Orion Recent Developments
Table 135. Stada Arzneimittel Basic Information
Table 136. Stada Arzneimittel Parkinson's Disease Therapeutics Product Overview
Table 137. Stada Arzneimittel Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Stada Arzneimittel Business Overview
Table 139. Stada Arzneimittel Recent Developments
Table 140. US WorldMeds Basic Information
Table 141. US WorldMeds Parkinson's Disease Therapeutics Product Overview
Table 142. US WorldMeds Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. US WorldMeds Business Overview
Table 144. US WorldMeds Recent Developments
Table 145. Desitin Arzneimittel Basic Information
Table 146. Desitin Arzneimittel Parkinson's Disease Therapeutics Product Overview
Table 147. Desitin Arzneimittel Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Desitin Arzneimittel Business Overview
Table 149. Desitin Arzneimittel Recent Developments
Table 150. Endo Pharmaceuticals Basic Information
Table 151. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Overview
Table 152. Endo Pharmaceuticals Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Endo Pharmaceuticals Business Overview
Table 154. Endo Pharmaceuticals Recent Developments
Table 155. Global Parkinson's Disease Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 156. Global Parkinson's Disease Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Parkinson's Disease Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 158. North America Parkinson's Disease Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Parkinson's Disease Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 160. Europe Parkinson's Disease Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Parkinson's Disease Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 162. Asia Pacific Parkinson's Disease Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Parkinson's Disease Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 164. South America Parkinson's Disease Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Parkinson's Disease Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Parkinson's Disease Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Parkinson's Disease Therapeutics Sales Forecast by Type (2026-2035) & (K Units)
Table 168. Global Parkinson's Disease Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Parkinson's Disease Therapeutics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 170. Global Parkinson's Disease Therapeutics Sales (K Units) Forecast by Application (2026-2035)
Table 171. Global Parkinson's Disease Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Parkinson's Disease Therapeutics Market Size by Type (M USD)
Table 4. Global Parkinson's Disease Therapeutics Market Size by Application
Table 5. Parkinson's Disease Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Parkinson's Disease Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Parkinson's Disease Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Parkinson's Disease Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Parkinson's Disease Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2025)
Table 11. Global Market Parkinson's Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Parkinson's Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson's Disease Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Parkinson's Disease Therapeutics Sales by Type (K Units)
Table 27. Global Parkinson's Disease Therapeutics Market Size by Type (M USD)
Table 28. Global Parkinson's Disease Therapeutics Sales (K Units) by Type (2020-2025)
Table 29. Global Parkinson's Disease Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Parkinson's Disease Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Parkinson's Disease Therapeutics Market Share by Type (2020-2025)
Table 32. Global Parkinson's Disease Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Parkinson's Disease Therapeutics Sales (K Units) by Application
Table 34. Global Parkinson's Disease Therapeutics Market Size by Application
Table 35. Global Parkinson's Disease Therapeutics Sales by Application (2020-2025) & (K Units)
Table 36. Global Parkinson's Disease Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Parkinson's Disease Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Parkinson's Disease Therapeutics Market Share by Application (2020-2025)
Table 39. Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Parkinson's Disease Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. Global Parkinson's Disease Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Parkinson's Disease Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Parkinson's Disease Therapeutics Market Size by Region (2020-2025)
Table 44. North America Parkinson's Disease Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. North America Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Parkinson's Disease Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Parkinson's Disease Therapeutics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Parkinson's Disease Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Parkinson's Disease Therapeutics Sales by Country (2020-2025) & (K Units)
Table 51. South America Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Parkinson's Disease Therapeutics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Parkinson's Disease Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Parkinson's Disease Therapeutics Production (K Units) by Region(2020-2025)
Table 55. Global Parkinson's Disease Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Parkinson's Disease Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Parkinson's Disease Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck Parkinson's Disease Therapeutics Product Overview
Table 64. Merck Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Akorn Basic Information
Table 69. Akorn Parkinson's Disease Therapeutics Product Overview
Table 70. Akorn Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Akorn Business Overview
Table 72. Akorn SWOT Analysis
Table 73. Akorn Recent Developments
Table 74. GSK Basic Information
Table 75. GSK Parkinson's Disease Therapeutics Product Overview
Table 76. GSK Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. GSK Business Overview
Table 78. GSK SWOT Analysis
Table 79. GSK Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Parkinson's Disease Therapeutics Product Overview
Table 82. Novartis Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Boehringer Ingelheim Basic Information
Table 86. Boehringer Ingelheim Parkinson's Disease Therapeutics Product Overview
Table 87. Boehringer Ingelheim Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Recent Developments
Table 90. Teva Pharmaceutical Basic Information
Table 91. Teva Pharmaceutical Parkinson's Disease Therapeutics Product Overview
Table 92. Teva Pharmaceutical Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Teva Pharmaceutical Business Overview
Table 94. Teva Pharmaceutical Recent Developments
Table 95. Abbvie Basic Information
Table 96. Abbvie Parkinson's Disease Therapeutics Product Overview
Table 97. Abbvie Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Abbvie Business Overview
Table 99. Abbvie Recent Developments
Table 100. Kyowa Hakko Kirin Pharma Basic Information
Table 101. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Overview
Table 102. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Kyowa Hakko Kirin Pharma Business Overview
Table 104. Kyowa Hakko Kirin Pharma Recent Developments
Table 105. Astellas Pharma Basic Information
Table 106. Astellas Pharma Parkinson's Disease Therapeutics Product Overview
Table 107. Astellas Pharma Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Astellas Pharma Business Overview
Table 109. Astellas Pharma Recent Developments
Table 110. Roche Basic Information
Table 111. Roche Parkinson's Disease Therapeutics Product Overview
Table 112. Roche Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Roche Business Overview
Table 114. Roche Recent Developments
Table 115. H.Lundbeck Basic Information
Table 116. H.Lundbeck Parkinson's Disease Therapeutics Product Overview
Table 117. H.Lundbeck Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. H.Lundbeck Business Overview
Table 119. H.Lundbeck Recent Developments
Table 120. Bausch Health Basic Information
Table 121. Bausch Health Parkinson's Disease Therapeutics Product Overview
Table 122. Bausch Health Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Bausch Health Business Overview
Table 124. Bausch Health Recent Developments
Table 125. Apokyn Basic Information
Table 126. Apokyn Parkinson's Disease Therapeutics Product Overview
Table 127. Apokyn Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Apokyn Business Overview
Table 129. Apokyn Recent Developments
Table 130. Orion Basic Information
Table 131. Orion Parkinson's Disease Therapeutics Product Overview
Table 132. Orion Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Orion Business Overview
Table 134. Orion Recent Developments
Table 135. Stada Arzneimittel Basic Information
Table 136. Stada Arzneimittel Parkinson's Disease Therapeutics Product Overview
Table 137. Stada Arzneimittel Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Stada Arzneimittel Business Overview
Table 139. Stada Arzneimittel Recent Developments
Table 140. US WorldMeds Basic Information
Table 141. US WorldMeds Parkinson's Disease Therapeutics Product Overview
Table 142. US WorldMeds Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. US WorldMeds Business Overview
Table 144. US WorldMeds Recent Developments
Table 145. Desitin Arzneimittel Basic Information
Table 146. Desitin Arzneimittel Parkinson's Disease Therapeutics Product Overview
Table 147. Desitin Arzneimittel Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Desitin Arzneimittel Business Overview
Table 149. Desitin Arzneimittel Recent Developments
Table 150. Endo Pharmaceuticals Basic Information
Table 151. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Overview
Table 152. Endo Pharmaceuticals Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Endo Pharmaceuticals Business Overview
Table 154. Endo Pharmaceuticals Recent Developments
Table 155. Global Parkinson's Disease Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 156. Global Parkinson's Disease Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Parkinson's Disease Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 158. North America Parkinson's Disease Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Parkinson's Disease Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 160. Europe Parkinson's Disease Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Parkinson's Disease Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 162. Asia Pacific Parkinson's Disease Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Parkinson's Disease Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 164. South America Parkinson's Disease Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Parkinson's Disease Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Parkinson's Disease Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Parkinson's Disease Therapeutics Sales Forecast by Type (2026-2035) & (K Units)
Table 168. Global Parkinson's Disease Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Parkinson's Disease Therapeutics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 170. Global Parkinson's Disease Therapeutics Sales (K Units) Forecast by Application (2026-2035)
Table 171. Global Parkinson's Disease Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Parkinson's Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson's Disease Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Parkinson's Disease Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Parkinson's Disease Therapeutics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson's Disease Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Parkinson's Disease Therapeutics Product Life Cycle
Figure 13. Parkinson's Disease Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Parkinson's Disease Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Parkinson's Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Parkinson's Disease Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Parkinson's Disease Therapeutics
Figure 19. Global Parkinson's Disease Therapeutics Market PEST Analysis
Figure 20. Global Parkinson's Disease Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Parkinson's Disease Therapeutics Market Share by Type
Figure 27. Sales Market Share of Parkinson's Disease Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Parkinson's Disease Therapeutics by Type in 2025
Figure 29. Market Share of Parkinson's Disease Therapeutics by Type (2020-2025)
Figure 30. Market Share of Parkinson's Disease Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Parkinson's Disease Therapeutics Market Share by Application
Figure 33. Global Parkinson's Disease Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Parkinson's Disease Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Parkinson's Disease Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Parkinson's Disease Therapeutics Market Share by Application in 2025
Figure 37. Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Parkinson's Disease Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Parkinson's Disease Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Parkinson's Disease Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Parkinson's Disease Therapeutics Market Size by Country in 2024
Figure 45. U.S. Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Parkinson's Disease Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Parkinson's Disease Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Parkinson's Disease Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Parkinson's Disease Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Parkinson's Disease Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Parkinson's Disease Therapeutics Market Size by Country in 2024
Figure 55. Germany Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Parkinson's Disease Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Parkinson's Disease Therapeutics Market Size by Region in 2024
Figure 68. China Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Parkinson's Disease Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Parkinson's Disease Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Parkinson's Disease Therapeutics Market Size by Country in 2024
Figure 82. Brazil Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Parkinson's Disease Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Parkinson's Disease Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Parkinson's Disease Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Parkinson's Disease Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Parkinson's Disease Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Parkinson's Disease Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Parkinson's Disease Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Parkinson's Disease Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Parkinson's Disease Therapeutics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Parkinson's Disease Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Parkinson's Disease Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Parkinson's Disease Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Parkinson's Disease Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Parkinson's Disease Therapeutics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Parkinson's Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson's Disease Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Parkinson's Disease Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Parkinson's Disease Therapeutics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson's Disease Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Parkinson's Disease Therapeutics Product Life Cycle
Figure 13. Parkinson's Disease Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Parkinson's Disease Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Parkinson's Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Parkinson's Disease Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Parkinson's Disease Therapeutics
Figure 19. Global Parkinson's Disease Therapeutics Market PEST Analysis
Figure 20. Global Parkinson's Disease Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Parkinson's Disease Therapeutics Market Share by Type
Figure 27. Sales Market Share of Parkinson's Disease Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Parkinson's Disease Therapeutics by Type in 2025
Figure 29. Market Share of Parkinson's Disease Therapeutics by Type (2020-2025)
Figure 30. Market Share of Parkinson's Disease Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Parkinson's Disease Therapeutics Market Share by Application
Figure 33. Global Parkinson's Disease Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Parkinson's Disease Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Parkinson's Disease Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Parkinson's Disease Therapeutics Market Share by Application in 2025
Figure 37. Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Parkinson's Disease Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Parkinson's Disease Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Parkinson's Disease Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Parkinson's Disease Therapeutics Market Size by Country in 2024
Figure 45. U.S. Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Parkinson's Disease Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Parkinson's Disease Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Parkinson's Disease Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Parkinson's Disease Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Parkinson's Disease Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Parkinson's Disease Therapeutics Market Size by Country in 2024
Figure 55. Germany Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Parkinson's Disease Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Parkinson's Disease Therapeutics Market Size by Region in 2024
Figure 68. China Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Parkinson's Disease Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Parkinson's Disease Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Parkinson's Disease Therapeutics Market Size by Country in 2024
Figure 82. Brazil Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Parkinson's Disease Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Parkinson's Disease Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Parkinson's Disease Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Parkinson's Disease Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Parkinson's Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Parkinson's Disease Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Parkinson's Disease Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Parkinson's Disease Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Parkinson's Disease Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Parkinson's Disease Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Parkinson's Disease Therapeutics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Parkinson's Disease Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Parkinson's Disease Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Parkinson's Disease Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Parkinson's Disease Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Parkinson's Disease Therapeutics Market Share Forecast by Application (2026-2035)
